Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05365607 · ClinicalTrials.gov registry record · NA

NightWare and Cardiovascular Health in Adults With PTSD

A NA study of Cardiovascular Diseases and Posttraumatic Stress Disorder, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT05365607 is a NA study of Cardiovascular Diseases and Posttraumatic Stress Disorder that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05365607, a NA study of Cardiovascular Diseases and Posttraumatic Stress Disorder, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular aging and autonomic function in adults with nightmares related to PTSD.

Interventions

  • DEVICE NightWare
  • DEVICE Sham NightWare

Study Locations (2)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora
  • University of Colorado CCTSI CTRC - Denver

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-06-24
Est. Completion 2024-08-18
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT05365607

The ClinicalTrials.gov registry entry for NCT05365607 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which NightWare is the first listed.

NCT05365607 reports 2 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05365607 about?

NCT05365607 is a clinical study titled "NightWare and Cardiovascular Health in Adults With PTSD". The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular aging and autonomic function in adults with nightmares related to PTSD.

What is the current status of trial NCT05365607?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-06-24. Estimated completion is 2024-08-18.

What conditions does trial NCT05365607 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Posttraumatic Stress Disorder, Endothelial Dysfunction, Vascular Stiffness, Autonomic Dysfunction.

What interventions are being tested in trial NCT05365607?

The interventions under investigation include: NightWare (DEVICE), Sham NightWare (DEVICE).

Who is sponsoring clinical trial NCT05365607?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05365607 being conducted?

This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.